BioPharm International
October 01, 2012
Issue PDF
25
10
Vaccine Packaging and Delivery Systems
October 01, 2012
Global Reports
25
10
India has enforced stricter patent laws compared to other countries. For a drug to be patentable in India, the invention has to be novel, inventive, and industrially applicable.
October 01, 2012
Features
25
10
The manufacturing capacity-sharing model between Merck and MedImmune ushers in a new paradigm of "co-opetition."
October 01, 2012
Final Word
25
10
Do you have to worry about FDA releasing confidential data? Apparently so.
October 01, 2012
Regulatory Beat
25
10
User fees aim to speed approvals and support inspections.
October 01, 2012
Global Reports
25
10
Recently published research demonstrates how nanoparticles can be used to overcome hurdles in localized drug delivery.
October 01, 2012
Features
25
10
Glenn Thorpe of West Pharmaceutical Services gives an update on packaging and delivery methods for vaccines.
October 01, 2012
Perspectives on Outsourcing
25
10
Measuring the size of the market for contract manufacturing services requires a careful hand.
October 01, 2012
Features
25
10
A new report highlights the industry's contributions to neglected diseases and calls for further collaboration.
October 01, 2012
Burrill on Biotech
25
10
A handful of therapeutics have performed extremely well in 2012, but as a whole, life-sciences are still down from 2010.
October 01, 2012
Features
25
10
Packaging vaccines using prefilled syringes can increase dosing efficiency, reduce costs, and improve patient safety. This article is part of a special section on vaccines.
October 01, 2012
Bioanalytical Best Practices
25
10
The complex structure of ADCs necessitates different analytical strategies than those for either small molecules or unconjugated monoclonal antibodies.
October 01, 2012
Boot Camp Technical Guide
25
10
NIBRT's Ian Nelligan on what to expect when starting a downstream process.
October 01, 2012
Inside USP
25
10
USP optimizes identification tests and impurities procedures.
October 01, 2012
Features
25
10
Understanding opportunities and challenges across all major phases of development.
October 01, 2012
Guest Editorial
25
10
Working together affords many unseen opportunities for pharmaceutical innovation.
October 01, 2012
From the Editor
25
10
Will the next US President support the backbone of our industry?
October 01, 2012
Features
25
10
Marco Chacon of Paragon Bioservices discusses the challenges associated with outsourced vaccine manufacturing.
October 01, 2012
Analytical Best Practices
25
10
Using an alternate moisture-generation method may provide more accurate data for regulatory submissions.
October 01, 2012
Features
25
10
MIT survey results address product and site characteristics that statistically correlate with quality performance.
October 01, 2012
Features
25
10
Anne Marie Dixon of Cleanroom Management Associates, gives us an update on her 1988 article, "Clean Room Management."